US FDA panel to discuss first psychedelic-assisted PTSD treatment next month

Explore stories from Atlantic Canada.

-The U.S. FDA's panel of independent advisers will on June 4 deliberate whether they should recommend approval for the first MDMA-assisted therapy for post-traumatic stress disorder, Lykos Therapeutics said on Monday.

Decades of studies has shown that psychoactive ingredients, whether derived from cannabis, LSD or magic mushrooms, have long captivated mental health researchers in their quest for treatments.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

SaltWire Network /  🏆 45. in CA

Canada Latest News, Canada Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Australia's ANZ Group announces $1.3 billion buyback, first-half cash earnings drop 7%Explore stories from Atlantic Canada.
Read more »

Microchip Technology expects weak quarterly results on excess inventory impactExplore stories from Atlantic Canada.
Read more »

Golf-Aberg withdraws from Quail Hollow with knee issueExplore stories from Atlantic Canada.
Read more »

US CDC asks states to make worker protective gear available to combat bird fluExplore stories from Atlantic Canada.
Read more »

US CDC asks states to make worker protective gear available to combat bird fluExplore stories from Atlantic Canada.
Read more »

Canadian First Nation rejects Obsidian Energy drilling expansion plansExplore stories from Atlantic Canada.
Read more »